NCT06893887 2025-07-02
ICT-HCC
Nanjing Tianyinshan Hospital
Phase NA Recruiting
Clinical Trials
6 trialsNCT05594927 2024-08-07
BESTPOP
Beijing Shenogen Biomedical Co., Ltd
Phase 3 Recruiting
NCT03236649 2023-02-08
The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects
Beijing Shenogen Biomedical Co., Ltd
Phase 3 Terminated
NCT01972672 2021-01-27
The Phase II Study of Icaritin in Patients With Advanced Hepatocellular Carcinoma
Beijing Shenogen Biomedical Co., Ltd
Phase 2 Completed
NCT02496949 2015-07-14
A Phase Ib Study to Assess Safety and Efficacy of Oral Icaritin in Advanced Solid Tumors
ChineseAMS
Phase 1 Completed
NCT01278810 2011-01-28
Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients
ChineseAMS
Phase 1 Unknown